Skip to main content

Venus Remedies

Healthcare NSE:VENUSREM

861.70INR
78.30 ( 9.99%)

Last update at March 11, 2026, midnight

Day Range

779.05861.70
LowHigh

52 Week Range

270.25 839.90
LowHigh

Fundamentals

  • Previous Close 783.40
  • Market Cap 9501.71M
  • Volume112,200
  • P/E Ratio 13.49
  • EBITDA 971.11M
  • Revenue TTM 6991.16M
  • Revenue Per Share TTM 523.45
  • Gross Profit TTM 3029.27M
  • Diluted EPS TTM 52.62

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 718.30M 446.43M 379.30M 364.08M 485.53M
Net income 453.20M 284.91M 265.70M 407.24M 617.65M
Total Revenue 6478.90M 5914.50M 5555.10M 5986.50M 5481.24M
Gross Profit 1662.70M 2182.59M 2245.20M 2004.14M 1961.66M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 7157.20M 6268.22M 6010.80M 5798.18M 5558.53M
Intangible assets 1047.25M 852.11M 792.46M 879.29M 967.16M
Other current assets 748.20M 735.25M 216.90M 344.06M 215.91M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 277.71M 277.44M -220.50M 143.76M 269.37M
Operating Cash 909.20M 372.85M 366.20M 410.01M 1326.14M
Free Cash Flow 812.90M 278.40M 288.02M 272.94M 1248.87M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
VENUSREM
Venus Remedies 		78.30 9.99% 861.70 9501.71 13.49
SUNPHARMA
Sun Pharmaceutical Industries Limited 		13.10 0.72% 1825.90 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-19.50 -0.31% 6352.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		3.40 0.08% 4431.20 1362716.66 63.48
CIPLA
Cipla Limited 		-4.00 -0.30% 1329.50 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.